#457 – Alan Foreman, CEO and Adrian Condon, CTO at B-Secur

Share This Post

Cardiac Monitoring Innovation - Episode Details

Join us on the latest episode, hosted by Jared S. Taylor! Our Guests: Alan Foreman, CEO and Adrian Condon, CTO at B-Secure.

What you’ll get out of this episode:
  • Introduction to Alan Foreman and Adrian Condon of B-Secur
  • The founding story and evolution of B-Secur
  • Challenges faced in developing and funding innovative cardiac technology
  • B-Secur’s unique approach to ECG signal processing
  • The future of cardiac monitoring and preventative healthcare

Watch

Listen

Read About Cardiac Monitoring Innovation

Introduction to B-Secur and Its Founders

In this episode of the Slice of Healthcare podcast, host Jared S. Taylor welcomes Alan Foreman, Chief Executive of B-Secur, and Adrian Condon, CTO and co-founder. Alan and Adrian share their journey in the world of cardiac monitoring and how their company, B-Secur, is making waves in the industry.

Founding Story of B-Secur

The idea for B-Secur was sparked nine years ago, shortly after the launch of the iPhone 6 with its revolutionary fingerprint sensor. Alan Foreman, with his extensive background in life sciences and technology, discovered a new approach to biometrics using ECG (electrocardiogram) signals. This next-generation biometric technology intrigued Adrian Condon, an expert in signal integrity and electromagnetics. Together, they embarked on a mission to develop a secure, innovative solution for cardiac monitoring.

Overcoming Challenges

Starting a tech company is never easy, especially when it involves deep R&D. Alan and Adrian faced significant challenges, particularly in securing funding. The European investment landscape was less receptive to deep tech ventures compared to the U.S. Despite these hurdles, their determination and innovative approach attracted the necessary investment to bring their vision to life.

Differentiators in Cardiac Monitoring Technology

B-Secur’s technology is unique in that it offers a software solution likened to the “Intel inside” of biosensing. Initially targeting sectors like FinTech and automotive, B-Secur shifted focus to consumer wellbeing and medical markets. Their software, which received FDA clearance, integrates seamlessly into various devices, enhancing the accuracy and functionality of ECG monitoring. This holistic approach, combining hardware knowledge with advanced software, sets B-Secur apart.

The Future of Cardiac Monitoring

The convergence of consumer wellbeing and medical technology excites both Alan and Adrian. They envision a future where continuous monitoring and early diagnosis of cardiovascular issues become the norm, potentially saving millions of lives. With cardiovascular disease being the leading cause of death globally, B-Secur’s preventative healthcare solutions could revolutionize the industry.

Embracing Failures and Moving Forward

Both founders emphasize the importance of persistence and learning from failures. Their journey is a testament to the power of resilience and the belief in their mission to improve cardiac health through innovative technology.

Finally, to learn more about our guest and their company please use the links below:

B-Secur Website


Also, be sure to follow Slice of Healthcare on our social channels:

Website  – LinkedIn – Twitter – YouTube – Newsletter

More To Explore

Total
0
Share